Patrick Waters
PhD FRCPath
Co-Director Autoimmune Neurology Diagnostic Laboratory
CNS autoimmunity, Assay development, Antibody cloning
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Websites
-
NHS Specialised Services for Neuromyelitis optica
NHS Specialised Services for Neuromyelitis optica
-
Guthy-Jackson NMO Website
Guthy-Jackson NMO Website
Recent publications
-
Prevalence of NMOSD and MS in the Indigenous Populations of Australia and New Zealand
Conference paper
Broadley SA. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP44 - NP44
-
Serum Cytokine Profiles of Myelin Oligodendrocyte Glycoprotein Encephalomyelitis
Conference paper
Kwon YN. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP88 - NP88
-
Cell-based assays for the detection of MOG antibodies: a comparative study.
Journal article
Gastaldi M. et al, (2020), J Neurol
-
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
Journal article
Michael S. et al, (2020), Pract Neurol
-
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
Journal article
O'Connell K. et al, (2020), J Neurol Neurosurg Psychiatry